Interesting. Reminds me of a conversation I had with a friend right after the call. Told him that big pharma companies are playing a dangerous game of chicken in terms of waiting to make CytoDyn a buyout offer. The dam is going to burst at some point in the near future, the stakes are just too high for it not to. One big pharma is going to break ranks and cave and make us a SUBSTANTIAL offer, and the rest are going to be on the outside looking in for all eternity. To the point of insolvency. That's obviously quite a hefty price to pay.
Anything below $50/share plus shares in the buyout company should be laughed out of the room at this point. The big pharma that swoops CYDY off its feet will go down in history as the one who got the prettiest girl (Leronlimab) in the whole auditorium by many orders of magnitude. And who doesn't want to be that "guy"?
Quote:
Cydy. I think they will be bought out before the end of this year.